These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 19505089

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    Ibrahim MA, Hazhirkarzar B, Dublin AB.
    ; 2024 01. PubMed ID: 29494094
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S, Ruloff R, Tóth E, Merbach AE.
    Chemistry; 2003 Aug 04; 9(15):3555-66. PubMed ID: 12898682
    [Abstract] [Full Text] [Related]

  • 6. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
    Xu J, Churchill DG, Botta M, Raymond KN.
    Inorg Chem; 2004 Sep 06; 43(18):5492-4. PubMed ID: 15332797
    [Abstract] [Full Text] [Related]

  • 7. 1,2-hydroxypyridonate/terephthalamide complexes of gadolinium(III): synthesis, stability, relaxivity, and water exchange properties.
    Werner EJ, Kozhukh J, Botta M, Moore EG, Avedano S, Aime S, Raymond KN.
    Inorg Chem; 2009 Jan 05; 48(1):277-86. PubMed ID: 19032045
    [Abstract] [Full Text] [Related]

  • 8. High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity.
    Jacques V, Dumas S, Sun WC, Troughton JS, Greenfield MT, Caravan P.
    Invest Radiol; 2010 Oct 05; 45(10):613-24. PubMed ID: 20808234
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    Zhang H.
    ; 2004 Oct 05. PubMed ID: 20641487
    [Abstract] [Full Text] [Related]

  • 13. Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity.
    Werner EJ, Avedano S, Botta M, Hay BP, Moore EG, Aime S, Raymond KN.
    J Am Chem Soc; 2007 Feb 21; 129(7):1870-1. PubMed ID: 17260995
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P.
    Acc Chem Res; 2009 Jul 21; 42(7):851-62. PubMed ID: 19222207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.
    Pierre VC, Botta M, Aime S, Raymond KN.
    Inorg Chem; 2006 Oct 02; 45(20):8355-64. PubMed ID: 16999435
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.